Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

The Zepbound Savings Card and Vials: Who Actually Qualifies

Who qualifies for the Zepbound savings card, LillyDirect vial and KwikPen self-pay prices by dose as of November 2026, the 45-day refill rule and what it skips.

Written by — editorial research, not medical advice
On this page

The short answer

As of November 21, 2026, Lilly runs two different deals under one "savings" banner. If your commercial insurance covers Zepbound, the savings card can bring the single-dose pen down to as little as $25 a fill. If you pay cash, the KwikPen or the vial starts at $299 at the 2.5 mg starting dose and is $449 at the higher doses only while you refill on time1,2. Anyone on Medicare, Medicaid, TRICARE or VA coverage is excluded from the card.

Why I sorted this out

The phrase I kept seeing was "Zepbound for $25," usually without the fine print. I went through Lilly's card terms and the LillyDirect product page line by line, and the honest version is that the $25 depends almost entirely on what your insurance already does. The dose-by-dose brand prices for both makers live in my Zepbound and Wegovy self-pay table. This page is about which offer you can actually use, and what each one leaves out.

Which offer fits your situation

Your situationWhat Lilly offersThe catch
Commercial insurance that covers ZepboundAs little as $25 for a 1-, 2- or 3-month fill of the single-dose penSavings capped at $100 a month and $1,300 a year, up to 13 fills
Commercial insurance that does not cover it, single-dose penAs low as $499 a monthNot the $299 price
Commercial insurance that does not cover it, KwikPen$299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg)$449 needs on-time refills
No insurance, or choosing not to use itKwikPen or vial at the same $299 / $399 / $449Cash only; cannot be billed to insurance
Medicare, Medicaid, TRICARE, VA, state programsNot eligible for the cardMedicare may qualify for the $50 Bridge

Source: Lilly's card terms1.

The 45-day rule

This is the line I would tape to the fridge. At 7.5 mg and above, the $449 price holds only if each refill is bought within 45 days of the delivery or receipt of the previous one. Miss it and the regular price applies: $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg2. A sick week, a trip or a delayed prescription renewal could cost $250 in one month, so I would write down every delivery date. If a dose increase is coming, I would ask for the new prescription early so the refill clock does not run out while I wait. Lilly's terms measure the 45 days from your previous KwikPen fill, so a change in strength does not reset the clock.

Vials vs the KwikPen

Both start at the same $299, and the escalation schedule is the same regardless of device2. The differences are practical:

  • Vials come only through LillyDirect and only for self-pay. You draw each dose with a needle and syringe, which you buy separately.
  • The KwikPen holds four weekly doses in one pen. You buy pen needles separately and attach a new one each week.
  • The single-dose pen is not part of the $299 self-pay price at all.

The label says to get training for the exact presentation you are prescribed, and again if it changes3. With a vial, that means learning to read the syringe for your dose rather than assuming pen instructions apply. Vials and loose syringes in a house with small children also need a plan, and the needle-safety steps I wrote up apply even more when the sharps are separate. I would keep them locked up and out of reach.

What the card does not cover

The savings apply to the medicine. They do not pay for the visit or membership that produced the prescription, and they do not cover the needles or syringes. Lilly lists the KwikPen and vials as HSA and FSA eligible, though that depends on your plan2. A telehealth service that prescribes brand-name Zepbound, such as Sesame Care or LifeMD, charges its own membership on top of the pharmacy price. I would add that membership to the monthly total before comparing.

The cash-pay card also does not count toward your deductible or out-of-pocket maximum, and you agree not to seek reimbursement from any insurer1. If your plan might cover Zepbound with a prior authorization, it is worth trying getting a GLP-1 covered before settling on cash. Medicaid rules for obesity drugs differ by state, which I track in GLP-1 coverage by state. The card terms say they end December 31, 2026, so I would expect new terms in January.

If you are on Medicare

The card is off the table, but the temporary Medicare GLP-1 Bridge lets eligible patients get Zepbound for no more than $50 a month1. It covers the KwikPen, runs from July 1, 2026 through December 31, 2027, and your prescriber has to confirm you meet the program's clinical criteria4.

Brand cash price vs compounded

At the top doses, $449 is still several times what compounded tirzepatide is advertised for. CoreAge Rx, for example, advertises compounded tirzepatide from $129 a month at every listed dose, though I would confirm the plan length and upfront charge. Compounded tirzepatide is a different product with different oversight, and the compounded vs brand trade-offs matter more than the price gap. The Wegovy savings offer follows a similar commercial-versus-cash split if you are weighing both makers. Novo's terms add a rule about stacking coupons that is worth knowing before you fill.

Before you pay

  1. Ask your insurer whether Zepbound is covered, and for which device.
  2. Price your expected maintenance dose, not the 2.5 mg starting dose.
  3. Put every delivery date in your calendar if you will be on 7.5 mg or higher.
  4. Check Lilly's page the week you fill, because these terms change.

If a new dose leaves you vomiting or unable to keep fluids down, call your prescriber before the next injection.

Frequently asked questions

Who qualifies for the Zepbound $25 savings card?

As of November 2026, the $25 price is for people with commercial insurance that covers the Zepbound single-dose pen, aged 18 or older and living in the US or Puerto Rico. Savings are capped at $100 a month and $1,300 a year. People on Medicare, Medicaid, TRICARE, VA, DoD or state assistance programs are not eligible.

How much are Zepbound vials without insurance?

On LillyDirect as of November 21, 2026, self-pay vials and KwikPens are $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg when each refill is bought within 45 days of the previous delivery. Otherwise the regular price is $499 at 7.5 mg and $699 at 10 mg and above. Vials are sold only through LillyDirect, and syringes are bought separately.

Does the Zepbound self-pay card count toward my deductible?

No. Lilly's self-pay card terms say it is for cash-paying patients only, that you will not seek reimbursement from any insurer, and that the cost is not applied toward deductibles or out-of-pocket requirements.

Can I use the Zepbound savings card on Medicare?

No. Government program members are excluded from the card. Eligible Medicare patients may instead get the Zepbound KwikPen for no more than $50 a month through the temporary Medicare GLP-1 Bridge, July 1, 2026 through December 31, 2027, if their prescriber confirms they meet its clinical criteria.

References

  1. Eli Lilly and Company (2026). Zepbound coverage and savings: Single-Dose Pen and KwikPen Savings Card terms, KwikPen Self-Pay Savings Card terms, purchase offer terms and Medicare GLP-1 Bridge. Eli Lilly and Company. https://zepbound.lilly.com/coverage-savings
  2. Eli Lilly and Company (2026). LillyDirect: Zepbound KwikPen, single-dose vial and single-dose pen self-pay prices by dose. Eli Lilly and Company. https://www.lilly.com/lillydirect/zepbound
  3. Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection — Prescribing Information: section 2.4 Important Administration Instructions and section 3 Dosage Forms and Strengths. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  4. KFF (Kaiser Family Foundation) (2026). What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge. KFF. https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.